Improved Glycemic Control in Poorly Controlled Patients with Type 1 Diabetes Using Real-Time Continuous Glucose Monitoring
Top Cited Papers
- 1 December 2006
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 29 (12) , 2730-2732
- https://doi.org/10.2337/dc06-1134
Abstract
Intensive self-management with frequent self-monitoring of blood glucose (SMBG) is important in type 1 diabetes to achieve good metabolic control (1–3). Nevertheless, many patients still experience episodes of unrecognized hypo- and hyperglycemia (4). Novel technologies for continuous glucose monitoring (CGM) that provide information about glucose excursions are now available. Previous studies reported the benefits of retrospective evaluation of CGM data (5–11), but few assessed effects on glycemic control (5,12–14), and only one showed improvements compared with SMBG (14). We evaluated the effect of a new real-time glucose monitor on glycemic control in patients with poorly controlled type 1 diabetes. The device, Guardian RT (Medtronic MiniMed, Northridge, CA), allows users to see glucose readings and set hypo- and hyperglycemic alarms and provides trend information on changing glucose values. The study included 81 children (median age 14.4 years [range 8.0–18.9]) and 81 adults (age 39.1 years [19.0–59.5]) with stable type 1 diabetes. All had adhered to intensified insulin treatment (continuous subcutaneous insulin infusion, n = 78; multiple daily injection, n = 84) but had HbA1c (A1C) levels ≥8.1%. Informed consent was obtained from patients regularly attending the eight participating centers. Subjects were randomly assigned 1:1:1 for 3 months to Guardian RT continuously (arm 1) or biweekly for 3-day periods every 2 weeks (arm 2) or to continue conventional SMBG (control). Treatment adjustments made by physicians and patients were based on SMBG profiles in control subjects and on real-time glucose profiles in arms 1 and 2. Patients were instructed to perform confirmatory SMBG measurements before therapeutical interventions or corrective action if hypo- or hyperglycemic alarms or symptoms occurred. …Keywords
This publication has 20 references indexed in Scilit:
- Accuracy of the Modified Continuous Glucose Monitoring (CGMS®) Sensor in an Outpatient Setting: Results from a Diabetes Research in Children Network (DirecNet) StudyDiabetes Technology & Therapeutics, 2005
- Use of the Continuous Glucose Monitoring System to Guide Therapy in Patients With Insulin-Treated Diabetes: A Randomized Controlled TrialMayo Clinic Proceedings, 2004
- Predictors of control of diabetes: monitoring may be the keyThe Journal of Pediatrics, 2004
- Searching for glycemic control in pediatric type 1 diabetes: A long way to goThe Journal of Pediatrics, 2001
- Predictors of glycemic control and short-term adverse outcomes in youth with type 1 diabetesThe Journal of Pediatrics, 2001
- Continuous Subcutaneous Glucose Monitoring in Children With Type 1 DiabetesPediatrics, 2001
- Self-Monitoring of Blood Glucose in Type I Diabetic Patients: Comparison With Continuous Microdialysis Measurements of Glucose in Subcutaneous Adipose Tissue During Ordinary Life ConditionsDiabetes Care, 1997
- The Relationship of Glycemic Exposure (HbA1c) to the Risk of Development and Progression of Retinopathy in the Diabetes Control and Complications TrialDiabetes, 1995
- Long-term continuous glucose monitoring with microdialysis in ambulatory insulin-dependent diabetic patientsThe Lancet, 1993
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993